Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06378866
Title Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial (DIVINE)
Acronym DIVINE
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.